SBC Medical Group Holdings (SBC) Sidoti Micro-Cap Virtual Investor Conference summary

Business overview and performance

• Largest aesthetic medical group in Japan, operating 258 franchise clinics with 6.5 million annual customers.

• Diversified services include orthopedics, ophthalmology, hair loss, and infertility treatments.

• Multi-branding and pricing strategies have driven a recovery in average revenue per customer visit.

• Q3 2025 saw sales bottoming out after restructuring and franchise fee revisions, with improved operating and net income.

• Maintains robust financial health, leveraging bank financing for growth and strategic investments.

Global expansion and partnership strategy

• Incremental global expansion focuses on partnerships, notably with OrangeTwist, a U.S. med spa operator.

• OrangeTwist operates 24 clinics across several U.S. states, offering a luxury med spa experience.

• Collaboration aims to leverage SBC's scale, medical expertise, and product development in the U.S. market.

• Plans include joint clinics, product distribution, and knowledge sharing between Japan and U.S. operations.

• Long-term vision targets being the most chosen medical group in Japan by 2035 and globally by 2050.

M&A and growth outlook

• Ongoing M&A activity prioritized in Japan, with potential for expansion in Southeast Asia and the U.S.

• Japanese M&A may extend beyond aesthetics to general medical fields like dentistry and orthopedics.

• Flexible platform allows for strategic adjustment and further clinic growth in Japan.

• Global growth expected to accelerate in 3–5 years, with incremental investments and partnerships.

• Focus remains on disciplined capital deployment and market knowledge before large-scale investments.